Mark has 20+ years of leadership experience in biotech & life sciences. He is motivated to find durable and safe treatments for blindness, influenced by his father’s retinitis pigmentosa. A former U.S. Air Force intelligence officer, Mark’s analytical problem-solving approach is backed by degrees in mechanical engineering and law. His dedication to innovation aims to positively impact those affected by vision impairment.